IIS: HL7 Standard Code Set
Mapping CVX to Vaccine Groups

Email Updates‎

Subscribe to receive email updates about this page.

A variety of vaccines can be used to vaccinate against a specific disease in fulfillment of the Advisory Committee on Immunization Practices (ACIP) schedule. Multiple individual vaccines that can be used to vaccinate against a disease are grouped into a Vaccine Group (sometimes known as vaccine family), and in many cases these groups represent vaccines that vaccinate against a single disease. In a few cases they represent vaccines that vaccinate against more than one disease, but are grouped together because clinicians have thought of them as a unit.

CVX codes are codes that indicate the product used in a vaccination. MVX codes are codes that indicate the manufacturer of a vaccine. These codes are maintained by the Centers for Disease Control and Prevention, Immunization Information System Support Branch (IISSB) for use in HL7 data transmission.

The goal of the table is to support mapping of CVX to vaccine groups.

Note: The column formerly known as "Uncertain Formulation CVX" has been changed to "CVX for Vaccine Group". This is the code to use for identifying the vaccine group in HL7 messages for forecasting next dose due and for other cases where vaccine group needs to be identified.

Questions regarding this table should be directed to the IIS Technical Assistance Team(or use mailing address).

Available Printable versions:

Sort Table by Column: Simply click on the column heading to sort the table accordingly.

Short Description	CVX Code	Vaccine status	Vaccine Group Name	CVX for Vaccine Group
DTP	01	Inactive	DTAP	107
OPV	02	Inactive	POLIO	89
MMR	03	Active	MMR	03
M/R	04	Inactive	MMR	03
measles	05	Inactive	MMR	03
rubella	06	Inactive	MMR	03
mumps	07	Inactive	MMR	03
Hep B, adolescent or pediatric	08	Active	HepB	45
Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed	09	Active	Td	139
IPV	10	Active	POLIO	89
pneumococcal conjugate PCV 7	100	Inactive	PneumoPCV	152
typhoid, ViCPs	101	Active	TYPHOID	91
DTP-Hib-Hep B	102	Non-US	DTAP	107
DTP-Hib-Hep B	102	Non-US	HepB	45
DTP-Hib-Hep B	102	Non-US	HIB	17
meningococcal C conjugate	103	Inactive	MENING	108
Hep A-Hep B	104	Active	HepA	85
Hep A-Hep B	104	Active	HepB	45
vaccinia (smallpox) diluted	105	Inactive	Orthopoxvirus	75
DTaP, 5 pertussis antigens	106	Active	DTAP	107
DTaP, unspecified formulation	107	Inactive	DTAP	107
meningococcal ACWY, unspecified formulation	108	Inactive	MENING	108
pneumococcal, unspecified formulation	109	Inactive	PneumoPCV	152
pneumococcal, unspecified formulation	109	Inactive	PneumoPPV	33
DTaP-Hep B-IPV	110	Active	DTAP	107
DTaP-Hep B-IPV	110	Active	HepB	45
DTaP-Hep B-IPV	110	Active	POLIO	89
Influenza, live, trivalent, intranasal	111	Active	FLU	88
Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed	113	Active	Td	139
meningococcal MCV4P	114	Active	MENING	108
Tdap	115	Active	TDAP	115
rotavirus, pentavalent	116	Active	ROTAVIRUS	122
HPV, bivalent	118	Inactive	HPV	137
rotavirus, monovalent	119	Active	ROTAVIRUS	122
DTaP-Hib-IPV	120	Active	HIB	17
DTaP-Hib-IPV	120	Active	DTAP	107
DTaP-Hib-IPV	120	Active	POLIO	89
zoster live	121	Active	ZOSTER	188
rotavirus, unspecified formulation	122	Inactive	ROTAVIRUS	122
influenza, H5N1-1203	123	Inactive	H5N1 flu	123
Novel Influenza-H1N1-09, nasal	125	Inactive	H1N1 flu	128
Novel influenza-H1N1-09, preservative-free	126	Inactive	H1N1 flu	128
Novel influenza-H1N1-09	127	Inactive	H1N1 flu	128
Novel Influenza-H1N1-09, all formulations	128	Inactive	H1N1 flu	128
Japanese Encephalitis, unspecified formulation	129	Inactive	Japanese encephalitis	129
DTaP-IPV	130	Active	POLIO	89
DTaP-IPV	130	Active	DTAP	107
DTaP-IPV-HIB-HEP B, historical	132	Inactive	POLIO	89
DTaP-IPV-HIB-HEP B, historical	132	Inactive	DTAP	107
DTaP-IPV-HIB-HEP B, historical	132	Inactive	HIB	17
DTaP-IPV-HIB-HEP B, historical	132	Inactive	HepB	45
Pneumococcal conjugate PCV 13	133	Active	PneumoPCV	152
Japanese Encephalitis IM	134	Active	Japanese encephalitis	129
Influenza, high-dose, trivalent, PF	135	Active	FLU	88
Meningococcal MCV4O	136	Active	MENING	108
HPV, unspecified formulation	137	Inactive	HPV	137
Td (adult)	138	Inactive	Td	139
Td(adult) unspecified formulation	139	Inactive	Td	139
Influenza, split virus, trivalent, PF	140	Active	FLU	88
Influenza, split virus, trivalent, preservative	141	Active	FLU	88
Adenovirus types 4 and 7	143	Active	ADENO	82
influenza, seasonal, intradermal, preservative free	144	Inactive	FLU	88
DTaP,IPV,Hib,HepB	146	Active	POLIO	89
DTaP,IPV,Hib,HepB	146	Active	DTAP	107
DTaP,IPV,Hib,HepB	146	Active	HIB	17
DTaP,IPV,Hib,HepB	146	Active	HepB	45
meningococcal MCV4, unspecified formulation	147	Inactive	MENING	108
Meningococcal C/Y-HIB PRP	148	Inactive	HIB	17
Meningococcal C/Y-HIB PRP	148	Inactive	MENING	108
Influenza, live, quadrivalent, intranasal	149	Active	FLU	88
influenza, split (incl. purified surface antigen)	15	Inactive	FLU	88
Influenza, split virus, quadrivalent, PF	150	Active	FLU	88
influenza nasal, unspecified formulation	151	Inactive	FLU	88
Pneumococcal Conjugate, unspecified formulation	152	Inactive	PneumoPCV	152
Influenza, MDCK, trivalent, PF	153	Active	FLU	88
Influenza, recombinant, trivalent, PF	155	Active	FLU	88
Influenza, split virus, quadrivalent, preservative	158	Active	FLU	88
influenza, whole	16	Inactive	FLU	88
Influenza A monovalent (H5N1), ADJUVANTED-2013	160	Active	H5N1 flu	123
Influenza, injectable,quadrivalent, preservative free, pediatric	161	Active	FLU	88
meningococcal B, recombinant	162	Active	MeningB	164
meningococcal B, OMV	163	Active	MeningB	164
meningococcal B, unspecified	164	Inactive	MeningB	164
HPV9	165	Active	HPV	137
influenza, intradermal, quadrivalent, preservative free	166	Inactive	FLU	88
Influenza, adjuvanted, trivalent, PF	168	Active	FLU	88
Hib, unspecified formulation	17	Inactive	HIB	17
DTAP/IPV/HIB - non-US	170	Non-US	POLIO	89
DTAP/IPV/HIB - non-US	170	Non-US	HIB	17
DTAP/IPV/HIB - non-US	170	Non-US	DTAP	107
Influenza, MDCK, quadrivalent, PF	171	Active	FLU	88
cholera, WC-rBS	172	Non-US	cholera	26
cholera, BivWC	173	Non-US	cholera	26
cholera, live attenuated	174	Active	cholera	26
Rabies - IM Diploid cell culture	175	Active	RABIES	90
Rabies - IM fibroblast culture	176	Active	RABIES	90
PCV10	177	Non-US	PneumoPCV	152
rabies, intramuscular injection	18	Inactive	RABIES	90
Yellow fever vaccine live - alt	183	Active	YELLOWFEVER	184
Yellow fever, unspecified	184	Inactive	YELLOWFEVER	184
Influenza, recombinant, quadrivalent, PF	185	Active	FLU	88
Influenza, MDCK, quadrivalent, preservative	186	Active	FLU	88
zoster recombinant	187	Active	ZOSTER	188
zoster, unspecified formulation	188	Inactive	ZOSTER	188
HepB-CpG	189	Active	HepB	45
BCG	19	Active	BCG	19
Hep A-Hep B, pediatric/adolescent	193	Non-US	HepB	45
Hep A-Hep B, pediatric/adolescent	193	Non-US	HepA	85
Influenza, Southern Hemisphere	194	Inactive	FLU	88
DT, IPV adsorbed	195	Non-US	Td	139
DT, IPV adsorbed	195	Non-US	POLIO	89
Td, adsorbed, preservative free, adult use, Lf unspecified	196	Active	Td	139
Influenza, high-dose, quadrivalent, PF	197	Active	FLU	88
DTaP	20	Active	DTAP	107
influenza, Southern Hemisphere, pediatric, preservative free	200	Active	FLU	88
influenza, Southern Hemisphere, preservative free	201	Active	FLU	88
influenza, Southern Hemisphere, quadrivalent, with preservative	202	Active	FLU	88
meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)	203	Active	MENING	108
Ebola Zaire vaccine, live, recombinant, 1mL dose	204	Active	Ebola	214
Influenza, adjuvanted, quadrivalent, PF	205	Active	FLU	88
Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection	206	Active	Orthopoxvirus	75
COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose	207	Inactive	COVID-19	213
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose	208	Inactive	COVID-19	213
varicella	21	Active	VARICELLA	21
COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL	210	Non-US	COVID-19	213
COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL	211	Inactive	COVID-19	213
COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL	212	Inactive	COVID-19	213
SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED	213	Inactive	COVID-19	213
Ebola, unspecified	214	Inactive	Ebola	214
Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF	215	Active	PneumoPCV	152
Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF	216	Active	PneumoPCV	152
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose	217	Inactive	COVID-19	213
COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose	218	Inactive	COVID-19	213
COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose	219	Inactive	COVID-19	213
DTP-Hib	22	Inactive	DTAP	107
DTP-Hib	22	Inactive	HIB	17
HepB recombinant, 3-antigen, Al(OH)3	220	Active	HepB	45
COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose	221	Inactive	COVID-19	213
Tick-borne encephalitis, unspecified	222	Inactive	Tick-borne encephalitis	222
Tick-borne encephalitis, inactivated, PF, 0.25mL	223	Active	Tick-borne encephalitis	222
Tick-borne encephalitis, inactivated, PF, 0.5mL	224	Active	Tick-borne encephalitis	222
COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL	225	Never Active	COVID-19	213
COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL	226	Never Active	COVID-19	213
COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose	227	Inactive	COVID-19	213
COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose	228	Inactive	COVID-19	213
COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose	229	Inactive	COVID-19	213
plague	23	Inactive	Plague	23
COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL	230	Inactive	COVID-19	213
influenza, Southern Hemisphere, high-dose, quadrivalent	231	Active	FLU	88
Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis	24	Active	ANTHRAX	319
typhoid, oral	25	Active	TYPHOID	91
cholera, unspecified formulation	26	Inactive	cholera	26
DT (pediatric)	28	Active	DTAP	107
COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose	300	Inactive	COVID-19	213
COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose	301	Inactive	COVID-19	213
COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose	302	Inactive	COVID-19	213
RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF	303	Active	RSV	304
Respiratory syncytial virus (RSV), unspecified	304	Inactive	RSV	304
RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF	305	Active	RSV	304
RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months	306	Active	RSV	304
RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months	307	Active	RSV	304
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL	308	Active	COVID-19	213
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL	309	Active	COVID-19	213
Hep A, pediatric, unspecified formulation	31	Inactive	HepA	85
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL	310	Active	COVID-19	213
COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL	311	Active	COVID-19	213
COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL	312	Active	COVID-19	213
COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL	313	Active	COVID-19	213
Respiratory syncytial virus (RSV) vaccine, unspecified	314	Inactive	RSV	304
Respiratory syncytial virus (RSV) MAB, unspecified	315	Inactive	RSV	304
Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF	316	Active	MENING	108
Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF	316	Active	MeningB	164
Chikungunya live attenuated vaccine, 0.5 mL, PF	317	Active	Chikungunya	317
Anthrax, post-exposure prophylaxis	318	Active	ANTHRAX	319
Anthrax vaccine, unspecified	319	Inactive	ANTHRAX	319
meningococcal MPSV4	32	Inactive	MENING	108
Influenza, MDCK, trivalent, preservative	320	Active	FLU	88
Influenza-avian, H5N8, monovalent, PF	321	Active	FLU-Avian-H5	323
Influenza-avian, H5N8, monovalent, preservative	322	Active	FLU-Avian-H5	323
Influenza-avian, H5, unspecified formulation	323	Inactive	FLU-Avian-H5	323
Poliovirus, inactivated, fractional-dose (fIPV)	324	Non-US	POLIO	89
RSV, mRNA, injectable, PF	326	Active	RSV	304
Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF	327	Active	PneumoPCV	152
pneumococcal polysaccharide PPV23	33	Active	PneumoPPV	33
tetanus toxoid, adsorbed	35	Inactive	Td	139
yellow fever live	37	Active	YELLOWFEVER	184
rubella/mumps	38	Inactive	MMR	03
Japanese encephalitis SC	39	Inactive	Japanese encephalitis	129
rabies, intradermal injection	40	Inactive	RABIES	90
typhoid, parenteral	41	Inactive	TYPHOID	91
Hep B, adolescent/high risk infant	42	Inactive	HepB	45
Hep B, adult	43	Active	HepB	45
Hep B, dialysis	44	Active	HepB	45
Hep B, unspecified formulation	45	Inactive	HepB	45
Hib (PRP-D)	46	Inactive	HIB	17
Hib (HbOC)	47	Inactive	HIB	17
Hib (PRP-T)	48	Active	HIB	17
Hib (PRP-OMP)	49	Active	HIB	17
DTaP-Hib	50	Inactive	DTAP	107
DTaP-Hib	50	Inactive	HIB	17
COVID-19 Non-US Vaccine, Product Unknown	500	Non-US	COVID-19	213
COVID-19 IV Non-US Vaccine (QAZCOVID-IN)	501	Non-US	COVID-19	213
COVID-19 IV Non-US Vaccine (COVAXIN)	502	Non-US	COVID-19	213
COVID-19 LAV Non-US Vaccine (COVIVAC)	503	Non-US	COVID-19	213
COVID-19 VVnr Non-US Vaccine (Sputnik Light)	504	Non-US	COVID-19	213
COVID-19 VVnr Non-US Vaccine (Sputnik V)	505	Non-US	COVID-19	213
COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology	506	Non-US	COVID-19	213
COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)	507	Non-US	COVID-19	213
COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)	508	Non-US	COVID-19	213
COVID-19 PS Non-US Vaccine (EpiVacCorona)	509	Non-US	COVID-19	213
Hib-Hep B	51	Inactive	HIB	17
Hib-Hep B	51	Inactive	HepB	45
COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)	510	Non-US	COVID-19	213
COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)	511	Non-US	COVID-19	213
SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)	512	Non-US	COVID-19	213
SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)	513	Non-US	COVID-19	213
SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)	514	Non-US	COVID-19	213
SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)	515	Non-US	COVID-19	213
COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)	516	Non-US	COVID-19	213
SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)	517	Non-US	COVID-19	213
COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)	518	Non-US	COVID-19	213
COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna	519	Non-US	COVID-19	213
Hep A, adult	52	Active	HepA	85
COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech	520	Non-US	COVID-19	213
COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK	521	Non-US	COVID-19	213
typhoid, parenteral, AKD (U.S. military)	53	Inactive	TYPHOID	91
adenovirus, type 4	54	Inactive	ADENO	82
adenovirus, type 7	55	Inactive	ADENO	82
dengue fever tetravalent	56	Active	DENGUE	56
HPV, quadrivalent	62	Active	HPV	137
Lyme disease	66	Inactive	Lyme disease	66
rotavirus, tetravalent	74	Inactive	ROTAVIRUS	122
vaccinia (smallpox)	75	Active	Orthopoxvirus	75
Tick-borne encephalitis vaccine (non-US)	77	Non-US	Tick-borne encephalitis	222
VEE, live	80	Inactive	VEE	92
VEE, inactivated	81	Inactive	VEE	92
adenovirus, unspecified formulation	82	Inactive	ADENO	82
Hep A, ped/adol, 2 dose	83	Active	HepA	85
Hep A, ped/adol, 3 dose	84	Inactive	HepA	85
Hep A, unspecified formulation	85	Inactive	HepA	85
influenza, unspecified formulation	88	Inactive	FLU	88
polio, unspecified formulation	89	Inactive	POLIO	89
rabies, unspecified formulation	90	Inactive	RABIES	90
typhoid, unspecified formulation	91	Inactive	TYPHOID	91
VEE, unspecified formulation	92	Inactive	VEE	92
MMRV	94	Active	MMR	03
MMRV	94	Active	VARICELLA	21

Top of Page

For further information on HL7 immunization data exchange and the CVX code set, contact the IIS Technical Assistance Team at:

Address:

CDC, National Centers for Immunization and Respiratory Diseases
Immunization Information System Support Branch - Informatics
1600 Clifton Road
Mailstop: E-62
Atlanta, GA 30333

Email:

iisinfo@cdc.gov (note change)

Page last reviewed: October 24, 2024

Content source: National Center for Immunization and Respiratory Diseases

IIS: HL7 Standard Code SetMapping CVX to Vaccine Groups

Email Updates‎

IIS: HL7 Standard Code Set
Mapping CVX to Vaccine Groups